Publications by authors named "J Guigay"

Claim this Profile
C
Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme Trial: TPEx Versus EXTREME as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Aldéric M Fraslin, Anne Aupérin, Caroline Even, Jérôme Fayette, Esma Saada-Bouzid, Joël Guigay

Value Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.
E Borcoman, A Hervieu, C Cropet, E Coquan, J Guigay

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
R Galot, C Le Tourneau, L Licitra, J Guigay, A Kong

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma.
Kevin Atsou, Anne Auperin, Jôel Guigay, Sébastien Salas, Sebastien Benzekry

CPT Pharmacometrics Syst Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation of perfect-crystal diffraction from Takagi-Taupin equations: numerical implementation in the crystalpy library.
Jean Pierre Guigay, Manuel Sanchez Del Rio

J Synchrotron Radiat· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis